MaveriX Oncology
About:
MaveriX Oncology is a globally-orientated biotechnology company.
Website: https://www.maverixoncology.com/
Top Investors: Sotio, PPF Group
Description:
MaveriX is a globally-orientated biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.Their technology approach leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers.
Total Funding Amount:
$6.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2014-01-01
Contact Email:
info(AT)maverixoncology.com
Founders:
Steven Everett
Number of Employees:
1-10
Last Funding Date:
2019-10-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai